D-dimer levels for risk stratification in patients with suspected covid-19 - a prospective observational study

  • Andrea S. Jauslin
  • John Kellett
  • Mikkel Brabrand
  • Noemi R. Simon
  • Marco Rueegg
  • Raphael Twerenbold
  • Stefan Osswald
  • Stefano Bassetti
  • Sarah Tschudin-Sutter
  • Martin Siegemund
  • Katharina Rentsch
  • Roland Bingisser
  • Christian H. Nickel

Abstract

Background: Elevated D-dimer levels have been observed in COVID-19 and are of prognostic value, but have not been compared to an appropriate control group. Methods: Observational cohort study including emergency patients with suspected or confirmed COVID-19. Logistic regression defined the association of D-dimer levels, COVID-19 positivity, age, and gender with 30-day-mortality. Results: 953 consecutive patients (median age 58, 43% women) presented with suspected COVID-19: 12 (7.4%) patients with confirmed SARS-CoV-2-infection died, compared with 28 (3.5%) patients without SARS-CoV-2-infection. Overall, most (56%) patients had elevated D-dimer levels (≥0.5mg/l). Age (OR 1.07, CI 1.05-1.10), D-dimer levels ≥0.5mg/l (OR 2.44, CI 0.98-7.39), and COVID-19 (OR 2.79, CI 1.28-5.80) were associated with 30-day-mortality. Conclusion: D-dimer levels are effective prognosticators in both patient groups.

Bibliographical data

Original languageEnglish
ISSN1747-4884
DOIs
Publication statusPublished - 2021
Externally publishedYes

Comment Deanary

Publisher Copyright:
© 2021 Rila Publications Ltd.